Ilan Hadar
Chairman and CEO at Silexion Therapeutics Corp
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Silexion Therapeutics Corp, 2 years.
Chief executive roles
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 15% of the scoring weight is on file.
- Earnings growth 15%
- 0
-55% a year in earnings per share
15% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Silexion Therapeutics Corp | Grant or award | +10,000 | — | — |
| Feb 20, 2026 | Silexion Therapeutics Corp | Grant or award | +64,350 | — | — |
Questions about Ilan Hadar
What boards is Ilan Hadar on?
Ilan Hadar sits on the board of Silexion Therapeutics Corp.
What company is Ilan Hadar the CEO of?
Ilan Hadar has been Chairman and CEO of Silexion Therapeutics Corp since August 2024.
How long has Ilan Hadar served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.